MedTrace Logo

VEST Device to Enhance Safein Vein Patency

NCT06500897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 385

Last updated 2024-07-16

No results posted yet for this study

Summary

Purpose - Bypass grafting is the gold standard for severe coronary disease, yet most repeat revascularizations target previously grafted territories. External stenting of saphenous vein grafts, the most frequently used bypass conduit, has been shown to minimize disease markers. This study evaluates clinical outcomes of external stenting in real world routine practice.

Methods - Three centers enrolled a prospective real-world cohort of external- stenting- enhanced CABG patients. All patients received an internal mammary artery graft to the left anterior descending artery and additional arterial and/or venous grafts. One or more venous grafts were externally stented. Choice of conduits, use of cardiopulmonary bypass, and vein harvesting technique were performed according to the routine practice of each surgeon.

All patients were prescribed standard of care medication and were followed via on site visits or phone interviews for major adverse myocardial and cerebral effects.

Conditions

  • Coronary Artery Bypass

Interventions

DEVICE

VEST

External MEsh Support for safein vein

Sponsors & Collaborators

  • Cardiochirurgia E.H.

    lead OTHER

Principal Investigators

  • Luca We · European Hospital - Rome

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-02
Primary Completion
2024-06-30
Completion
2024-07-08

Countries

  • Austria
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06500897 on ClinicalTrials.gov